Sakakibara M, Shimoyama H, Nomura M, Nakashima C, Hirabayashi M, Sei Y, Kuwano Y (2019) Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
Tirzepatide (Mounjaro) was approved in May 2022 for adults with type 2 diabetes, with the brand name Zepbound approved in November 2023 for obesity
Semaglutide Guide Tirzepatide Guide Retatrutide Guide Guide FAQ Quick answers about guide scope, access, and educational use context
Although they are useful for extending shelf life and inhibiting microbial spoilage, they may also have negative effects on the quality of food
[3] Post-laser resurfacing
Its essential for anyone considering an aesthetic treatment to do their research and choose a reputable practitioner